Moderna Cancer Vaccine Trial Sends Shares Soaring Higher
NEW YORK: (News Desk) - Moderna shares surged after the biotechnology company and Merck & Co. reported positive preliminary results from a late-stage trial of their experimental personalized cancer vaccine, marking a…